SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients

Immunocompromised patients (ICPs) have a higher risk of developing severe forms of COVID-19 and experience a higher burden of complications and mortality than the general population. However, recent studies have suggested that the antibody response to SARS-CoV-2 mRNA vaccines could be highly variabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordry, Natacha, Mamez, Anne-Claire, Fedeli, Chiara, Cantero, Chloé, Jaksic, Cyril, Alonso, Pilar Ustero, Rayroux, Caroline, Berra, Gregory, Portillo, Vera, Puntel, Maeva, Yerly, Sabine, Bugeia, Sébastien, Gutknecht, Garance, Di Marco, Mariagrazia, Mach, Nicolas, Soccal, Paola Marina, Chalandon, Yves, Calmy, Alexandra, Addeo, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459936/
https://www.ncbi.nlm.nih.gov/pubmed/37631852
http://dx.doi.org/10.3390/vaccines11081284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459936/
https://www.ncbi.nlm.nih.gov/pubmed/37631852
http://dx.doi.org/10.3390/vaccines11081284

Ejemplares similares